The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
Drug prices outpace inflation, new study shows
By
Haymarket Media
Nov 16, 2005
Prices for brand-name drugs outpaced the rate of inflation over the past year, a new study shows.
Clinical Briefs for Wednesday, February 12
By
Alicia Lasek
Feb 11, 2020
EMR records may be enough to predict dementia risk: study … New bill seeks additional oversight of Medicare hospice providers … Build-up of brain proteins affects genes in Alzheimer’s disease...
Also in the News for Tuesday, March 26, 2024
By
Josh Henreckson
Mar 26, 2024
Court denies nursing home software developer $3.5 million refund … Bipartisan bill would accelerate dementia workforce preparedness … Researchers pinpoint genes, changes related to Alzheimer’s disease
Clinical Briefs for Tuesday, April 14
By
Alicia Lasek
Apr 13, 2020
Gene variant staves off Alzheimer’s in some people, scientists find … Virtual training keeps assisted living med-techs certified during pandemic … Tips for contact lens and glasses-wearers during...
Webster Printing responds to COVID-19
By
Kimberly Marselas
Apr 01, 2020
A commercial printing and sign company has launched a new division dedicated to social distancing sign solutions. Massachusetts-based Webster Printing offers an in-house design and creative services team...
Governors eye block grants as way to cut Medicaid costs
By
John O'Connor
Jul 01, 2011
House Republicans would like to see Medicaid outlays trimmed dramatically. And they are hardly alone.
Pharmacists push for study before implementing short-cycle dispensing rule
Mar 23, 2011
The National Community Pharmacists Association on Tuesday called for the Centers for Medicare & Medicaid Services to collect additional data before implementing a rule that would shorten the medication...
Secondary analysis gives blood thinner apixaban nod over warfarin
By
Alicia Lasek
Feb 24, 2020
Apixaban (Eliquis) may present fewer risks for stroke patients than warfarin, the study found. Meanwhile, anticoagulant use has risen in nursing homes.
Medicare tops to-do list for lawmakers
Jan 14, 2008
Legislators are planning to resume discussions about Medicare after passing slimmed-down legislation on this program before the winter recess.